Insiders · DRNA

Patrick M. Gray

Director at Dicerna Pharmaceuticals Inc (DRNA)

Patrick M. Gray has filed 2 insider reports with the SEC since June 2021, as director at Dicerna Pharmaceuticals Inc (DRNA). The latest filing, on December 29, 2021, reports sale back to the company and tender of shares in a change of control at Dicerna Pharmaceuticals Inc (DRNA).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Patrick M. Gray is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Dicerna Pharmaceuticals Inc logo
DRNA
Dicerna Pharmaceuticals Inc
Director0Dec 29, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Patrick M. Gray with

Questions about Patrick M. Gray

What is Patrick M. Gray's role at Dicerna Pharmaceuticals Inc?
Patrick M. Gray reports to the SEC as director at Dicerna Pharmaceuticals Inc (DRNA), according to the latest filing on December 29, 2021.
Has Patrick M. Gray bought or sold stock recently?
No open-market purchases or sales by Patrick M. Gray are on file. The filings report sale back to the company, tender of shares in a change of control, grant or award and exercise or conversion of a derivative.
How do I get alerts when Patrick M. Gray files?
Follow Patrick M. Gray on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Patrick M. Gray (SEC CIK 0001619328). Totals count each trade once, skipping amendments whose original is on file, from Jun 8, 2021 on. View on SEC EDGAR · Get this as JSON